These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 33940518)
21. Hybrid nanoparticles coated with hyaluronic acid lipoid for targeted co-delivery of paclitaxel and curcumin to synergistically eliminate breast cancer stem cells. Yang Z; Sun N; Cheng R; Zhao C; Liu J; Tian Z J Mater Chem B; 2017 Sep; 5(33):6762-6775. PubMed ID: 32264326 [TBL] [Abstract][Full Text] [Related]
22. Switching indication of PEGylated lipid nanocapsules-loaded with rolapitant and deferasirox against breast cancer: Enhanced in-vitro and in-vivo cytotoxicity. Kabil MF; Mahmoud MY; Bakr AF; Zaafar D; El-Sherbiny IM Life Sci; 2022 Sep; 305():120731. PubMed ID: 35753435 [TBL] [Abstract][Full Text] [Related]
23. Salinomycin possesses anti-tumor activity and inhibits breast cancer stem-like cells via an apoptosis-independent pathway. An H; Kim JY; Lee N; Cho Y; Oh E; Seo JH Biochem Biophys Res Commun; 2015 Oct; 466(4):696-703. PubMed ID: 26407842 [TBL] [Abstract][Full Text] [Related]
24. Polymer-lipid hybrid anti-HER2 nanoparticles for targeted salinomycin delivery to HER2-positive breast cancer stem cells and cancer cells. Li J; Xu W; Yuan X; Chen H; Song H; Wang B; Han J Int J Nanomedicine; 2017; 12():6909-6921. PubMed ID: 29075110 [TBL] [Abstract][Full Text] [Related]
25. Combination of drug-conjugated SWCNT nanocarriers for efficient therapy of cancer stem cells in a breast cancer animal model. Al Faraj A; Shaik AS; Ratemi E; Halwani R J Control Release; 2016 Mar; 225():240-51. PubMed ID: 26827662 [TBL] [Abstract][Full Text] [Related]
26. Salinomycin reduces stemness and induces apoptosis on human ovarian cancer stem cell. Lee HG; Shin SJ; Chung HW; Kwon SH; Cha SD; Lee JE; Cho CH J Gynecol Oncol; 2017 Mar; 28(2):e14. PubMed ID: 27894167 [TBL] [Abstract][Full Text] [Related]
27. Dual-Targeted Delivery of Nanoparticles Encapsulating Paclitaxel and Everolimus: a Novel Strategy to Overcome Breast Cancer Receptor Heterogeneity. Houdaihed L; Evans JC; Allen C Pharm Res; 2020 Jan; 37(3):39. PubMed ID: 31965330 [TBL] [Abstract][Full Text] [Related]
28. Development of multifunctional lipid nanocapsules for the co-delivery of paclitaxel and CpG-ODN in the treatment of glioblastoma. Lollo G; Vincent M; Ullio-Gamboa G; Lemaire L; Franconi F; Couez D; Benoit JP Int J Pharm; 2015 Nov; 495(2):972-80. PubMed ID: 26428632 [TBL] [Abstract][Full Text] [Related]
29. Salinomycin exerts anticancer effects on human breast carcinoma MCF-7 cancer stem cells via modulation of Hedgehog signaling. Lu Y; Ma W; Mao J; Yu X; Hou Z; Fan S; Song B; Wang H; Li J; Kang L; Liu P; Liu Q; Li L Chem Biol Interact; 2015 Feb; 228():100-7. PubMed ID: 25499043 [TBL] [Abstract][Full Text] [Related]
30. Combined nanomedicines targeting colorectal cancer stem cells and cancer cells. Tsakiris N; Fauvet F; Ruby S; Puisieux A; Paquot A; Muccioli GG; Vigneron AM; Préat V J Control Release; 2020 Oct; 326():387-395. PubMed ID: 32702392 [TBL] [Abstract][Full Text] [Related]
31. Curcumin-Loaded Nanostructure Hybrid Lipid Capsules for Co-eradication of Breast Cancer and Cancer Stem Cells with Enhanced Anticancer Efficacy. Yadava SK; Basu SM; Valsalakumari R; Chauhan M; Singhania M; Giri J ACS Appl Bio Mater; 2020 Oct; 3(10):6811-6822. PubMed ID: 35019344 [TBL] [Abstract][Full Text] [Related]
32. Anticancer properties of lipid and poly(ε-caprolactone) nanocapsules loaded with ferrocenyl-tamoxifen derivatives. Najlaoui F; Pigeon P; Aroui S; Pezet M; Sancey L; Marrakchi N; Rhouma A; Jaouen G; De Waard M; Busser B; Gibaud S J Pharm Pharmacol; 2018 Nov; 70(11):1474-1484. PubMed ID: 30141195 [TBL] [Abstract][Full Text] [Related]
33. Co-Eradication of Breast Cancer Cells and Cancer Stem Cells by Cross-Linked Multilamellar Liposomes Enhances Tumor Treatment. Kim YJ; Liu Y; Li S; Rohrs J; Zhang R; Zhang X; Wang P Mol Pharm; 2015 Aug; 12(8):2811-22. PubMed ID: 26098197 [TBL] [Abstract][Full Text] [Related]
34. MicroRNA-200c delivered by solid lipid nanoparticles enhances the effect of paclitaxel on breast cancer stem cell. Liu J; Meng T; Yuan M; Wen L; Cheng B; Liu N; Huang X; Hong Y; Yuan H; Hu F Int J Nanomedicine; 2016; 11():6713-6725. PubMed ID: 28003747 [TBL] [Abstract][Full Text] [Related]
35. Toxicological study and efficacy of blank and paclitaxel-loaded lipid nanocapsules after i.v. administration in mice. Hureaux J; Lagarce F; Gagnadoux F; Rousselet MC; Moal V; Urban T; Benoit JP Pharm Res; 2010 Mar; 27(3):421-30. PubMed ID: 20054705 [TBL] [Abstract][Full Text] [Related]
36. Concurrently suppressing multidrug resistance and metastasis of breast cancer by co-delivery of paclitaxel and honokiol with pH-sensitive polymeric micelles. Wang Z; Li X; Wang D; Zou Y; Qu X; He C; Deng Y; Jin Y; Zhou Y; Zhou Y; Liu Y Acta Biomater; 2017 Oct; 62():144-156. PubMed ID: 28842335 [TBL] [Abstract][Full Text] [Related]
37. Enhancing Chemosensitivity of Breast Cancer Stem Cells by Downregulating SOX2 and ABCG2 Using Wedelolactone-encapsulated Nanoparticles. Das S; Mukherjee P; Chatterjee R; Jamal Z; Chatterji U Mol Cancer Ther; 2019 Mar; 18(3):680-692. PubMed ID: 30587555 [TBL] [Abstract][Full Text] [Related]
38. The eradication of breast cancer cells and stem cells by 8-hydroxyquinoline-loaded hyaluronan modified mesoporous silica nanoparticle-supported lipid bilayers containing docetaxel. Wang D; Huang J; Wang X; Yu Y; Zhang H; Chen Y; Liu J; Sun Z; Zou H; Sun D; Zhou G; Zhang G; Lu Y; Zhong Y Biomaterials; 2013 Oct; 34(31):7662-73. PubMed ID: 23859657 [TBL] [Abstract][Full Text] [Related]
39. Lipid and Biosurfactant Based Core-Shell-Type Nanocapsules Having High Drug Loading of Paclitaxel for Improved Breast Cancer Therapy. Katiyar SS; Ghadi R; Kushwah V; Dora CP; Jain S ACS Biomater Sci Eng; 2020 Dec; 6(12):6760-6769. PubMed ID: 33320604 [TBL] [Abstract][Full Text] [Related]
40. Combination therapy targeting both cancer stem-like cells and bulk tumor cells for improved efficacy of breast cancer treatment. Wang T; Narayanaswamy R; Ren H; Torchilin VP Cancer Biol Ther; 2016 Jun; 17(6):698-707. PubMed ID: 27259361 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]